ID27937A - Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut - Google Patents

Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut

Info

Publication number
ID27937A
ID27937A IDW20002566A ID20002566A ID27937A ID 27937 A ID27937 A ID 27937A ID W20002566 A IDW20002566 A ID W20002566A ID 20002566 A ID20002566 A ID 20002566A ID 27937 A ID27937 A ID 27937A
Authority
ID
Indonesia
Prior art keywords
formoterols
budesonides
prevention
treatment
composition
Prior art date
Application number
IDW20002566A
Other languages
English (en)
Indonesian (id)
Inventor
Tommy Ekstrom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20411658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27937(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID27937A publication Critical patent/ID27937A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IDW20002566A 1998-06-11 1999-06-10 Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut ID27937A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802073A SE9802073D0 (sv) 1998-06-11 1998-06-11 New use

Publications (1)

Publication Number Publication Date
ID27937A true ID27937A (id) 2001-05-03

Family

ID=20411658

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002566A ID27937A (id) 1998-06-11 1999-06-10 Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut

Country Status (35)

Country Link
US (2) US20010049396A1 (ar)
EP (3) EP1085877B1 (ar)
JP (1) JP2002517450A (ar)
KR (1) KR20010052721A (ar)
CN (1) CN100389771C (ar)
AR (1) AR018410A1 (ar)
AT (1) ATE389409T1 (ar)
AU (1) AU771715B2 (ar)
BR (1) BR9911073A (ar)
CA (1) CA2334411C (ar)
CY (1) CY1110376T1 (ar)
CZ (1) CZ300874B6 (ar)
DE (1) DE69938390T2 (ar)
DK (1) DK1085877T3 (ar)
EE (1) EE05661B1 (ar)
ES (1) ES2302384T3 (ar)
HK (1) HK1035145A1 (ar)
HU (1) HUP0103108A3 (ar)
ID (1) ID27937A (ar)
IL (2) IL139921A0 (ar)
IS (1) IS5752A (ar)
MY (1) MY129281A (ar)
NO (3) NO20006253L (ar)
NZ (1) NZ536279A (ar)
PL (1) PL344665A1 (ar)
PT (1) PT1085877E (ar)
RU (1) RU2222332C2 (ar)
SA (1) SA99200234B1 (ar)
SE (1) SE9802073D0 (ar)
SK (1) SK286252B6 (ar)
TR (1) TR200003666T2 (ar)
TW (1) TWI252756B (ar)
UA (1) UA87956C2 (ar)
WO (1) WO1999064014A1 (ar)
ZA (1) ZA200006943B (ar)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
EA005179B1 (ru) 2000-05-22 2004-12-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Стабильные фармацевтические препараты в виде растворов для дозированных ингаляторов под давлением
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
JP4837892B2 (ja) * 2001-11-01 2011-12-14 ネクター セラピューティクス 粉末バッチを製造する方法
FI20020126A0 (fi) * 2002-01-23 2002-01-23 Orion Corp Koostumuksia pulmonaaliseen antoon
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0219511D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
JP4744876B2 (ja) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド 乾燥粉末吸入組成物の製造方法
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20070098644A1 (en) * 2005-10-31 2007-05-03 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
JP5825757B2 (ja) 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするｄｈｅの治療上の投与方法
CA2677573A1 (en) 2007-02-19 2008-08-28 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
EP1982709A1 (en) 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
LT2435023T (lt) 2009-05-29 2016-09-26 Pearl Therapeutics, Inc. Kompozicijos, skirtos ilgai veikiančių muskarininių antagonistų ir ilgai veikiančių beta-2-adrenerginio receptoriaus agonistų pristatymui į plaučius, ir susiję būdai bei sistemos
PT2538922T (pt) * 2010-02-25 2016-07-11 Andi-Ventis Ltd Formulação de composições para o tratamento de doenças inflamatórias
JP2013531056A (ja) * 2010-07-16 2013-08-01 シプラ・リミテッド Ｒ（＋）ブデソニド及び１以上の気管支拡張剤を含む医薬組成物
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US9061352B2 (en) 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
CN102416179B (zh) * 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
EP4008326A1 (en) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
JOP20120023B1 (ar) 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
CN107596518B (zh) 2012-02-29 2021-04-23 普马特里克斯营业公司 可吸入干粉剂
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
JP6473738B2 (ja) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド チオトロピウム乾燥粉末
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
TW201735914A (zh) * 2015-12-22 2017-10-16 阿斯特捷利康公司 用於治療慢性阻塞性肺疾病之醫藥組成物
IT202000006442A1 (it) 2020-03-27 2021-09-27 Genetic S P A Budesonide 21-phosphate salts and pharmaceutical compositions containing the same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203401A (en) 1979-01-29 1980-05-20 General Motors Corporation Evaporative emissions canister
CA2024872C (en) 1989-09-08 2002-07-09 James Barry Douglas Palmer Medicaments
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5119791A (en) 1991-06-07 1992-06-09 General Motors Corporation Vapor storage canister with liquid trap
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
HU227519B1 (en) * 1991-12-18 2011-07-28 Astra Ab Synergic pharmaceutical composition containing combination of formoterol and budesonide
EP0613371B1 (en) 1991-12-18 2002-03-06 AstraZeneca AB New combination of formoterol and budesonide
US5408977A (en) 1993-08-23 1995-04-25 Walbro Corporation Fuel tank with carbon canister and shut-off valve
WO1995009615A1 (en) 1993-10-01 1995-04-13 Astra Aktiebolag Process i
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5511957A (en) 1994-09-27 1996-04-30 Walbro Corporation High capacity fuel pump and filter combination
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
EA002124B1 (ru) 1995-11-24 2001-12-24 Смитклайн Бичам С.П.А. Производные хинолина
US5651349A (en) 1995-12-11 1997-07-29 Chrysler Corporation Purge system flow monitor and method
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP1009408A1 (en) 1997-06-27 2000-06-21 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US5957114A (en) 1998-07-17 1999-09-28 Ford Motor Company Evaporative emission canister for an automotive vehicle
US5924410A (en) 1998-07-20 1999-07-20 Ford Motor Company Evaporative emission canister for an automotive vehicle
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6227862B1 (en) * 1999-02-12 2001-05-08 Advanced Drivers Education Products And Training, Inc. Driver training system
EP1031725B1 (en) 1999-02-26 2004-12-29 Walbro Corporation Vehicle fuel system
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
US6237574B1 (en) 1999-04-20 2001-05-29 Ford Motor Company Evaporative emission canister for an automotive vehicle
US6136075A (en) 1999-05-03 2000-10-24 Westvaco Corporation Automotive evaporative emissions canister adsorptive restraint system
JP3646217B2 (ja) 1999-07-08 2005-05-11 愛三工業株式会社 キャニスタモジュール
US6374811B1 (en) 2000-10-04 2002-04-23 Ford Global Technologies, Inc. System and method for minimizing fuel evaporative emissions from an internal combustion engine

Also Published As

Publication number Publication date
MY129281A (en) 2007-03-30
PT1085877E (pt) 2008-05-13
EP1085877B1 (en) 2008-03-19
UA87956C2 (uk) 2009-09-10
NO20140823L (no) 2001-02-12
EE200000740A (et) 2002-04-15
JP2002517450A (ja) 2002-06-18
NO20006253L (no) 2001-02-12
AR018410A1 (es) 2001-11-14
US20040063676A1 (en) 2004-04-01
CZ300874B6 (cs) 2009-09-02
PL344665A1 (en) 2001-11-19
EP1316311A1 (en) 2003-06-04
SA99200234B1 (ar) 2007-03-10
AU4671099A (en) 1999-12-30
BR9911073A (pt) 2001-02-20
US9295644B2 (en) 2016-03-29
CN1305380A (zh) 2001-07-25
TR200003666T2 (tr) 2001-06-21
CA2334411A1 (en) 1999-12-16
SE9802073D0 (sv) 1998-06-11
IS5752A (is) 2000-12-05
US20010049396A1 (en) 2001-12-06
DE69938390D1 (de) 2008-04-30
NO20006253D0 (no) 2000-12-08
EE05661B1 (et) 2013-06-17
CY1110376T1 (el) 2015-04-29
NZ536279A (en) 2007-01-26
DE69938390T2 (de) 2009-03-05
HUP0103108A3 (en) 2002-11-28
WO1999064014A1 (en) 1999-12-16
AU771715B2 (en) 2004-04-01
CZ20004593A3 (cs) 2001-04-11
EP2266574A1 (en) 2010-12-29
ATE389409T1 (de) 2008-04-15
TWI252756B (en) 2006-04-11
HK1035145A1 (en) 2001-11-16
SK18882000A3 (sk) 2001-07-10
CN100389771C (zh) 2008-05-28
ES2302384T3 (es) 2008-07-01
IL139921A (en) 2006-10-05
ZA200006943B (en) 2002-02-27
HUP0103108A2 (hu) 2002-05-29
NO20130269L (no) 2001-02-12
DK1085877T3 (da) 2008-06-09
RU2222332C2 (ru) 2004-01-27
EP1085877A1 (en) 2001-03-28
KR20010052721A (ko) 2001-06-25
IL139921A0 (en) 2002-02-10
SK286252B6 (sk) 2008-06-06
CA2334411C (en) 2008-07-15

Similar Documents

Publication Publication Date Title
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
DE60010662D1 (de) Kombinationen von formoterol und fluticasonpropionat für asthma
HUP0104496A3 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID27667A (id) Komposisi coklat dan pemakaiannya
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
BR9612555A (pt) Composições de detergente que contêm precursores de fragância e os precursores de fragância dessas composições
ID28382A (id) Bahan anti keringat dan komposisi-komposisi yang mengandung bahan anti keringat
ID28277A (id) Komposisi-komposisi yang terdiri dari analog-analog gaba dan kaffein
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
PT853959E (pt) Composicao para o tratamento do amianto
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
ID29871A (id) Turunan-turunan morfolin baru, metode pembuatannya dan komposisi-komposisi farmasi yang mengandungnya
SI1085877T1 (sl) Uporaba sestavka, ki obsega formoterol in budezonid, za preprečevanje ali zdravljenje akutnega stanja
ID26079A (id) Budidaya mikroba yang mempunyai aktivitas glutaminase meningkat dan penggunaannya
ID30541A (id) Peptida-peptida kecil dan penggunannya pada penyembuhan asma dan radang
ID28262A (id) Komposisi herbal untuk propilaksis dan pengobatan aids
HUP9903881A3 (en) Benzenesulfonamide derivatives usable for the prevention and/or treatment of thrombosis, asthma or allergic and use thereof
ID18781A (id) Komposisi obat rempah dan plester herbal yang dibuat darinya
SI1156790T1 (en) Combinations of formoterol and mometasone furoate
HU0203768D0 (en) Combination containing cgmpe inhibitor and gabapentine or pregabaline